Survival of severe ARDS with five-organ system failure following burns and inhalation injury in a 15-year-old patient

Burns

Volumn 29, Issue 4, 2003, Pages 389-394

  Cedidi, Can ^a   Hierner, Robert ^a   Pichlmaier, Maximilian ^a   Forssmann, Wolf Georg ^a   Meyer, Markus ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

ARDS; Burns; ECMO; NO; Surfactant; Urodilatin

Indexed keywords

ADRENALIN; ALBUMIN; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; BLOOD CLOTTING FACTOR; FRESH FROZEN PLASMA; LUNG SURFACTANT EXTRACT; NITRIC OXIDE; NORADRENALIN; URODILATIN;

ADOLESCENT; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBIOTIC THERAPY; ARTICLE; BODY SURFACE; BRAIN INJURY; BRAIN ISCHEMIA; BRONCHOSCOPY; BURN; CASE REPORT; CLINICAL FEATURE; DERMIS; DEVICE; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE COURSE; DISEASE SEVERITY; DRUG INFUSION; HEART ARREST; HEART FAILURE; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; KIDNEY FAILURE; KINETICS; LABORATORY TEST; LIVER FAILURE; LUNG FUNCTION; LUNG INFECTION; LUNG INSUFFICIENCY; LUNG VENTILATION; MALE; MULTIPLE ORGAN FAILURE; OXYGEN BREATHING; OXYGENATION; PARENTERAL NUTRITION; PNEUMONIA; RESPIRATORY FAILURE; RESUSCITATION; SKINFOLD THICKNESS; SMALL INTESTINE OBSTRUCTION; SURVIVAL RATE; THERMAL INJURY; TREATMENT OUTCOME;

EID: 0038823530     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-4179(03)00010-X     Document Type: Article

References (34)

1. Benmeir P., Sagi A., Greber B., Vardy D., Lusthaus S., Picard E.et al. An analysis of mortality in patients with burns covering 40% BSA or more: a retrospective review covering 24 years (1964-1988). Burns. 17(5):1991;402-405.
2. Thompson P.B., Herndon D.N., Traber D.L., Abston S. Effect on mortality of inhalation injury. J. Trauma. 26(2):1986;163-165.
3. Anderson H.L. III, Attorri R.J., Custer J.R., Chapman R.A., Bartlett R.H. Extracorporeal membrane oxygenation for pediatric cardiopulmonary failure. J. Thorac. Cardiovasc. Surg. 99(6):1990;1011-1019.
4. Lessin M.S., el Eid S.E., Klein M.D., Cullen M.L. Extracorporeal membrane oxygenation in pediatric respiratory failure secondary to smoke inhalation injury. J. Pediatr. Surg. 31(9):1996;1285-1287.
5. Bartlett R.H. Extracorporeal life support for cardiopulmonary failure. Curr. Probl. Surg. 27(10):1990;621-705.
6. Egan T.M., Duffin J., Glynn M.F., Todd T.R., DeMajo W., Murphy E.et al. Ten-year experience with extracorporeal membrane oxygenation for severe respiratory failure. Chest. 94(4):1988;681-687.
7. Rossaint R., Falke K.J., Lopez F., Slama K., Pison U., Zapol W.M. Inhaled nitric oxide for the adult respiratory distress syndrome. New Engl. J. Med. 328(6):1993;399-405.
8. Oulton M.R., Janigan D.T., MacDonald J.M., Faulkner G.T., Scott J.E. Effects of smoke inhalation on alveolar surfactant subtypes in mice. Am. J. Pathol. 145(4):1994;941-950.
9. Pallua N., Warbanow K., Noah E.M., Machens H.G., Poets C., Bernhard W.et al. Intrabronchial surfactant application in cases of inhalation injury: first results from patients with severe burns and ARDS. Burns. 24(3):1998;197-206.
10. Mehta U., Laks H., Sadeghi A., Marelli D., Odim J., Alejos J.et al. Extracorporeal membrane oxygenation for cardiac support in pediatric patients. Am. Surg. 66(9):2000;879-886.
11. Kawahito K., Nose Y. Hemolysis in different centrifugal pumps. Artif. Organs. 21(4):1997;323-326.
12. Meyer M., Richter R., Forssmann W.G. Urodilatin: a natriuretic peptide with clinical implications. Eur. J. Med. Res. 3(1-2):1998;103-110.
13. Cedidi C., Meyer M., Kuse E.R., Schulz-Knappe P., Ringe B., Frei U.et al. Urodilatin: a new approach for the treatment of therapy-resistant acute renal failure after liver transplantation. Eur. J. Clin. Invest. 24(9):1994;632-639.
14. Fluge T., Fabel H., Wagner T.O., Schneider B., Forssmann W.G. Urodilatin (ularitide, INN): a potent bronchodilator in asthmatic subjects. Eur. J. Clin. Invest. 25(10):1995;728-736.
15. Ullrich R., Lorber C., Roder G., Urak G., Faryniak B., Sladen R.N.et al. Controlled airway pressure therapy, nitric oxide-inhalation, prone position, and extracorporeal membrane oxygenation (ECMO) as components of an integrated approach to ARDS. Anesthesiology. 91(6):1999;1577-1586.
16. 2 removal in severe acute respiratory failure. JAMA. 256(7):1986;881-886.
17. Langer M., Mascheroni D., Marcolin R., Gattinoni L. The prone position in ARDS patients: a clinical study. Chest. 94(1):1988;103-107.
18. Guinard N., Beloucif S., Gatecel C., Mateo J., Payen D. Interest of a therapeutic optimization strategy in severe ARDS. Chest. 111(4):1997;1000-1007.
19. Lewandowski K., Rossaint R., Pappert D., Gerlach H., Slama K.J., Weidemann H.et al. High survival rate in 122 ARDS patients managed according to a clinical algorithm including extracorporeal membrane oxygenation. Intensive Care Med. 23(8):1997;819-835.
20. Kinsella J.P., Abman S.H. Methaemoglobin during nitric oxide therapy with high-frequency ventilation. Lancet. 342(8871):1993;615.
21. Germann P., Poschl G., Leitner C., Urak G., Ullrich R., Faryniak B.et al. Additive effect of nitric oxide-inhalation on the oxygenation benefit of the prone position in the adult respiratory distress syndrome. Anesthesiology. 89(6):1998;1401-1406.
22. Nelson L.D., Choi S.C. Kinetic therapy in critically ill trauma patients. Clin. Intensive Care. 3(6):1992;248-252.
23. Matthay M.A., Wiener-Kronish J.P. Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Am. Rev. Respir. Dis. 142:1990;1250-1257.
24. Milberg J.A., Davis D.R., Steinberg K.P., Hudson L.D. Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993. JAMA. 273(4):1995;306-309.
25. Hummel M., Kuhn M., Bub A., Mann B., Schneider B., von Eickstedt K.W.et al. Urodilatin: a new therapy to prevent kidney failure after heart transplantation. J. Heart Lung Transplant. 12(2):1993;209-217.
26. Davis C.L., Kausz A.T., Zager R.A., Kharasch E.D., Cochran R.P. Acute renal failure after cardiopulmonary bypass in relation to decreased serum ferritin levels. J. Am. Soc. Nephrol. 10(11):1999;2396-2402.
27. Zapol W.M., Snider M.T., Hill J.D., Fallat R.J., Bartlett R.H., Edmunds L.H.et al. Extracorporeal membrane oxygenation in severe acute respiratory failure: a randomized prospective study. JAMA. 242(20):1979;2193-2196.
28. Kawahito S., Maeda T., Yoshikawa M., Takano T., Nonaka K., Linneweber J.et al. Blood trauma induced by clinically accepted oxygenators. ASAIO J. 47(5):2001;492-495.
29. Davis S.L., Furman D.P., Costarino A.T. Jr. Adult respiratory distress syndrome in children: associated disease, clinical course, and predictors of death. J. Pediatr. 123(1):1993;35-45.
30. DeBruin W., Notterman D.A., Magid M., Godwin T., Johnston S. Acute hypoxemic respiratory failure in infants and children: clinical and pathologic characteristics. Crit. Care Med. 20(9):1992;1223-1234.
31. Timmons O.D., Dean J.M., Vernon D.D. Mortality rates and prognostic variables in children with adult respiratory distress syndrome. J. Pediatr. 119(6):1991;896-899.
32. Keenan H.T., Bratton S.L., Martin L.D., Crawford S.W., Weiss N.S. Outcome of children who require mechanical ventilatory support after bone marrow transplantation. Crit. Care Med. 28(3):2000;830-835.
33. Green T.P., Timmons O.D., Fackler J.C., Moler F.W., Thompson A.E., Sweeney M.F. The impact of extracorporeal membrane oxygenation on survival in pediatric patients with acute respiratory failure: Pediatric Critical Care Study Group. Crit. Care Med. 24(2):1996;323-329.
34. Brogan T.V., Bratton S.L., Meyer R.J., O'Rourke P.P., Jardine D.S. Non-pulmonary organ failure and outcome in children treated with high-frequency oscillatory ventilation. J. Crit. Care. 15(1):2000;5-11.